CASR and Alzheimer disease: In conclusion, we demonstrated that CaSR is involved in oligomeric Aβ1–42-induced cognitive dysfunction as well as synapse formation and developmental impairment in the pathogenesis of AD, in addition, our results indicated that cPLA2 and PGE2 are downstream targets of CaSR, which mediate cognitive decline in AD.